The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Tracking global funding for the prevention and control of noncommunicable diseases
Open accessAbstract
Despite increased global aid for development and health – from 5.6 billion United States dollars (US$) in 1990 to US$ 21.8 billion in 20071 – donors and wider society have become sceptical about the benefits of this aid. This is reflected in a call recently issued by the Bill and Melinda Gates Foundation’s Grand Challenges Explorations programme for innovative ways to better convey to the public the benefits of global aid.2 Poor tracking of programme outcomes and of funding for global health by both donors and recipients, a problem widely recognized, contributes to the growing doubts.3-4 A United Nations High Level Meeting (UNHLM) held in September 2011 focussed attention on noncommunicable diseases (NCDs).5 Almost two thirds of all deaths in the world are caused by NCDs, many of which are preventable,6 yet NCDs have received relatively little attention and funding.7 They were excluded from the Millennium Development Goals.8 Although the lack of measurable “hard” outcomes (e.g. targets for reduction in mortality or increased access to medicines) emanating from the UNHLM disappointed many, media coverage of the meeting undoubtedly put the spotlight on NCDs. Encouragingly, the UNHLM revealed singularity of purpose across the global health community.5 Participants agreed that identifying common NCD risk factors and integrating approaches for NCD control are crucial, but saw as the greatest challenge the implementation of broader health system changes in low- and low-middle income countries to produce more sustainable, long-term effects.5-6 Failure to learn from the past and to scrutinize the factors currently hindering efforts to control communicable diseases and improve maternal and child health, including non-transparent tracking of programme funding and finances, will undermine efforts to combat NCDs. Better metrics and improved monitoring and reporting of health outcomes, funding and finances will facilitate programme success. NCD control and monitoring of programme funding should occur at the country and regional levels, since insufficient data on global health financing makes comprehensive auditing of funds nearly impossible. On a global scale, reported increases in health funding may be overblown and there may be no way to know whether the funds really reach the intended recipients.3 The shaky economy may lead to reduced health aid for several countries and create the need for improved monitoring and efficiency.3,4 There are also potential conflicts of interest among the many parties involved in the multi-billion dollar industry that global health represents.4 When Sridhar & Batniji tracked funding from the major global health donors, such as The World Bank and the Global Fund, they found that “the pluralism of global health institutions and the informal alliances on which power in global health rests make a unified and fully coordinated health system highly unlikely”.3 Inadequate coordination and bureaucracy have plagued global health aid and the NCD community must take heed. Lessons can be more widely shared and previous mistakes more easily avoided through coordination of methods and data across countries. New efforts to control NCDs should be worked into the existing health-care infrastructure and global programmes.7 Transparency in funding, programme delivery and outcome data, as well as local ownership, will enable improved monitoring and a global health architecture actively prepared for change instead of passively reactive to it. The data collected by donors and aid recipients on the global burden of disease and on financing requirements must be standardized to enable monitoring and comparisons across health programmes and systems. Common data gathering mechanisms for all diseases and global health programmes, as well as improved monitoring of the data furnished by both funders and recipients, will ensure better tracking of finances, resources and, ultimately, outcomes. This will in turn heighten accountability and responsibility on all sides. Country-level ownership of NCD programmes will make governments and local players more inclined to “buy into” policy-making and planning and will put financial and outcome data within the public’s reach. Despite a call for “a quantitative, scientific framework to guide health-care scale-up in developing countries”,9 the scale-up of NCD prevention and treatment programmes is hampered by lack of measurable targets and disagreement on the policies and interventions required. Evidence-based global health interventions relevant to low- and low-middle income settings sometimes conflicts with quick, pragmatic policy-making.10 New research is necessary to design the best evidence-based policies for the control of NCDs, but a thorough understanding of the policies’ sociopolitical and cultural ramifications should underlie their design and implementation.10 Importantly, inadequate tracking and non-transparency of NCD programme finances, funding and ou
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Priority actions for the non-communicable disease crisis
Beaglehole, R., Bonita, R., Horton, R., Adams, C., Alleyne, G., Asaria, P., Baugh, V., Bekedam, H., Billo, N., Casswell, S., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60393-0 · Cited by 1,615
Grand challenges in chronic non-communicable diseases
Daar, A. S., Singer, P. A., Leah Persad, D., Pramming, S. K., Matthews, D. R., Beaglehole, R., Bernstein, A., Borysiewicz, L. K., Colagiuri, S., Ganguly, N., et al. (2007) · Nature · doi:10.1038/450494a · Cited by 701
Financing of global health: tracking development assistance for health from 1990 to 2007
Ravishankar, N., Gubbins, P., Cooley, R. J., Leach-Kemon, K., Michaud, C. M., Jamison, D. T., & Murray, C. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60881-3 · Cited by 558
Global health funding: how much, where it comes from and where it goes
McCoy, D., Chand, S., & Sridhar, D. (2009) · Health Policy and Planning · doi:10.1093/heapol/czp026 · Cited by 329
Scaling up global health interventions: A proposed framework for success
Yamey, G. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001049 · Cited by 295
Misfinancing global health: a case for transparency in disbursements and decision making
Sridhar, D., & Batniji, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61485-3 · Cited by 204
The United Nations Millennium Development Goals
Szekeres, D. (2012) · Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) · Cited by 187
Where Have All the Donors Gone? Scarce Donor Funding for Non-Communicable DiseasesPreprint
Nugent, R. A., & Feigl, A. B. (2010) · SSRN Electronic Journal · doi:10.2139/ssrn.1824392 · Cited by 107
Evidence-based policymaking in global health - the payoffs and pitfalls
Yamey, G., & Feachem, R. G. (2011) · BMJ Evidence-Based Medicine · doi:10.1136/ebm.2011.100060 · Cited by 44
Nugent, R. A. (2010) · RePEc: Research Papers in Economics · Cited by 37
Cited by
Priority actions for the non-communicable disease crisis
Beaglehole, R., Bonita, R., Horton, R., Adams, C., Alleyne, G., Asaria, P., Baugh, V., Bekedam, H., Billo, N., Casswell, S., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60393-0 · Cited by 1,615
Monitoring of Vital Signs with Flexible and Wearable Medical Devices
Khan, Y., Ostfeld, A. E., Lochner, C. M., Pierre, A., & Arias, A. C. (2016) · Advanced Materials · doi:10.1002/adma.201504366 · Cited by 1,408
Popkin, B. M., Du, S., Green, W. D., Beck, M. A., Algaith, T., Herbst, C. H., Alsukait, R. F., Alluhidan, M., Alazemi, N., & Shekar, M. (2020) · Obesity Reviews · doi:10.1111/obr.13128 · Cited by 1,150
Early-life exposure to EDCs: role in childhood obesity and neurodevelopment
Braun, J. M. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.186 · Cited by 930
Samdal, G. B., Eide, G. E., Barth, T., Williams, G., & Meland, E. (2017) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-017-0494-y · Cited by 788
Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults
Satman, I., Omer, B., Tutuncu, Y., Kalaca, S., Gedik, S., Dinccag, N., Karsidag, K., Genc, S., Telci, A., Canbaz, B., et al. (2013) · European Journal of Epidemiology · doi:10.1007/s10654-013-9771-5 · Cited by 786
Flax and flaxseed oil: an ancient medicine & modern functional food
Goyal, A., Sharma, V., Upadhyay, N., Gill, S., & Sihag, M. (2014) · Journal of Food Science and Technology · doi:10.1007/s13197-013-1247-9 · Cited by 742
Energy balance and obesity: what are the main drivers?
On behalf of the IARC working group on Energy Balance and Obesity, Romieu, I., Dossus, L., Barquera, S., Blottière, H. M., Franks, P. W., Gunter, M., Hwalla, N., Hursting, S. D., Leitzmann, M., et al. (2017) · Cancer Causes & Control · doi:10.1007/s10552-017-0869-z · Cited by 739
Swinburn, B., Sacks, G., Vandevijvere, S., Kumanyika, S., Lobstein, T., Neal, B., Barquera, S., Friel, S., Hawkes, C., Kelly, B., et al. (2013) · Obesity Reviews · doi:10.1111/obr.12087 · Cited by 676
The increasing burden and complexity of multimorbidity
Koné Pefoyo, A. J., Bronskill, S. E., Gruneir, A., Calzavara, A., Thavorn, K., Petrosyan, Y., Maxwell, C. J., Bai, Y., & Wodchis, W. P. (2015) · BMC Public Health · doi:10.1186/s12889-015-1733-2 · Cited by 597
Planning cancer control in Latin America and the Caribbean
Goss, P. E., Lee, B. L., Badovinac-Crnjevic, T., Strasser-Weippl, K., Chavarri-Guerra, Y., Louis, J. S., Villarreal-Garza, C., Unger-Saldaña, K., Ferreyra, M., Debiasi, M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70048-2 · Cited by 499
Al-Hazzaa, H. M., Abahussain, N. A., Al-Sobayel, H. I., Qahwaji, D. M., & Musaiger, A. O. (2011) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/1479-5868-8-140 · Cited by 470
Hanson, M. A., Bardsley, A., De-Regil, L. M., Moore, S. E., Oken, E., Poston, L., Ma, R. C., McAuliffe, F. M., Maleta, K., Purandare, C. N., et al. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30023-0 · Cited by 413
Multiple health behaviours: overview and implications
Spring, B., Moller, A. C., & Coons, M. J. (2012) · Journal of Public Health · doi:10.1093/pubmed/fdr111 · Cited by 408
Antihypertensive peptides from animal products, marine organisms, and plants
Lee, S. Y., & Hur, S. J. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2017.02.039 · Cited by 389
Effectiveness of mHealth interventions for patients with diabetes: An overview of systematic reviews
Kitsiou, S., Paré, G., Jaana, M., & Gerber, B. (2017) · PLOS ONE · doi:10.1371/journal.pone.0173160 · Cited by 388
A global view on the development of non communicable diseases
Wagner, K.-H., & Brath, H. (2012) · Preventive Medicine · doi:10.1016/j.ypmed.2011.11.012 · Cited by 362
Swinburn, B., Vandevijvere, S., Kraak, V., Sacks, G., Snowdon, W., Hawkes, C., Barquera, S., Friel, S., Kelly, B., Kumanyika, S., et al. (2013) · Obesity Reviews · doi:10.1111/obr.12073 · Cited by 306
Direito, A., Pfaeffli Dale, L., Shields, E., Dobson, R., Whittaker, R., & Maddison, R. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-646 · Cited by 305
Pratt, M., Sarmiento, O. L., Montes, F., Ogilvie, D., Marcus, B. H., Perez, L. G., & Brownson, R. C. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60736-3 · Cited by 295
Developmental origins of noncommunicable disease: population and public health implications
Hanson, M., & Gluckman, P. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.001206 · Cited by 291
Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension
Rust, P., & Ekmekcioglu, C. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2016_147 · Cited by 286
Healthy food subsidies and unhealthy food taxation: A systematic review of the evidence
Niebylski, M. L., Redburn, K. A., Duhaney, T., & Campbell, N. R. (2015) · Nutrition · doi:10.1016/j.nut.2014.12.010 · Cited by 279
Lee, J. T., Hamid, F., Pati, S., Atun, R., & Millett, C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127199 · Cited by 278
Cleven, L., Krell-Roesch, J., Nigg, C. R., & Woll, A. (2020) · BMC Public Health · doi:10.1186/s12889-020-08715-4 · Cited by 277
Fatty acid profile of edible oils and fats consumed in India
Dorni, C., Sharma, P., Saikia, G., & Longvah, T. (2018) · Food Chemistry · doi:10.1016/j.foodchem.2017.05.072 · Cited by 271
Müller, A. M., Alley, S., Schoeppe, S., & Vandelanotte, C. (2016) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-016-0434-2 · Cited by 213
Global Oral Health Inequalities: Task Group—Implementation and Delivery of Oral Health Strategies
Sheiham, A., Alexander, D., Cohen, L., Marinho, V., Moysés, S., Petersen, P. E., Spencer, J., Watt, R. G., & Weyant, R. (2011) · Advances in Dental Research · doi:10.1177/0022034511402084 · Cited by 221
Body fat distribution and the risk of incident metabolic syndrome: A longitudinal cohort study
Kwon, H., Kim, D., & Kim, J. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-09723-y · Cited by 205
Buse, K., Tanaka, S., & Hawkes, S. (2017) · Globalization and Health · doi:10.1186/s12992-017-0255-3 · Cited by 175
Huntriss, R., Campbell, M., & Bedwell, C. (2018) · European Journal of Clinical Nutrition · doi:10.1038/s41430-017-0019-4 · Cited by 170
Naicker, K., Johnson, J. A., Skogen, J. C., Manuel, D., Øverland, S., Sivertsen, B., & Colman, I. (2017) · Diabetes Care · doi:10.2337/dc16-2018 · Cited by 148
Fibrates for secondary prevention of cardiovascular disease and stroke
Wang, D., Liu, B., Tao, W., Hao, Z., & Liu, M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009580.pub2 · Cited by 142
Effective tobacco control is key to rapid progress in reduction of non-communicable diseases
Glantz, S., & Gonzalez, M. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60615-6 · Cited by 99
Chung, C.-F., Wang, Q., Schroeder, J., Cole, A., Zia, J., Fogarty, J., & Munson, S. A. (2019) · Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies · doi:10.1145/3314394 · Cited by 93
Political priority in the global fight against non-communicable diseases
Maher, A., & Sridhar, D. (2012) · Journal of Global Health · doi:10.7189/jogh.02.020403 · Cited by 93
Roache, S. A., & Gostin, L. O. (2017) · International Journal of Health Policy and Management · doi:10.15171/ijhpm.2017.69 · Cited by 87
(2020) · doi:10.1186/s12889-020-09700-7 · Cited by 77
Celis-Morales, C., Livingstone, K. M., Woolhead, C., Forster, H., O’Donovan, C. B., Macready, A. L., Fallaize, R., Marsaux, C. F. M., Tsirigoti, L., Efstathopoulou, E., et al. (2015) · Genes & Nutrition · doi:10.1007/s12263-015-0476-0 · Cited by 69
Doustmohammadian, A., Omidvar, N., & Shakibazadeh, E. (2020) · Systematic Reviews · doi:10.1186/s13643-020-01339-0 · Cited by 50
Hissa, M. N. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0180-2 · Cited by 1
Metadata
- Authors
- Banerjee, A.
- Venue
- Bulletin of the World Health Organization
- Publisher
- WHO Press
- Published
- 2012-07-01
- Volume
- 90
- Issue
- 7
- Pages
- 479-479A
- ISSN
- 0042-9686 (ISSN-L)
- OpenAlex
- W2139041145
- Cited by
- 606
- References
- 10
- FWCI
- 101.44
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.